Lindbrook Capital’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $11.1K | Sell |
256
-251
| -50% | -$10.9K | ﹤0.01% | 1604 |
|
2024
Q4 | $28.5K | Buy |
507
+10
| +2% | +$562 | ﹤0.01% | 1092 |
|
2024
Q3 | $33.9K | Buy |
497
+343
| +223% | +$23.4K | ﹤0.01% | 1008 |
|
2024
Q2 | $6.51K | Sell |
154
-268
| -64% | -$11.3K | ﹤0.01% | 1868 |
|
2024
Q1 | $29.1K | Buy |
422
+143
| +51% | +$9.88K | ﹤0.01% | 1022 |
|
2023
Q4 | $20.6K | Buy |
279
+151
| +118% | +$11.2K | ﹤0.01% | 1159 |
|
2023
Q3 | $8.73K | Sell |
128
-44
| -26% | -$3K | ﹤0.01% | 1485 |
|
2023
Q2 | $16.2K | Buy |
172
+55
| +47% | +$5.17K | ﹤0.01% | 1203 |
|
2023
Q1 | $7.93K | Hold |
117
| – | – | ﹤0.01% | 1600 |
|
2022
Q4 | $5.79K | Buy |
117
+18
| +18% | +$891 | ﹤0.01% | 1737 |
|
2022
Q3 | $3K | Buy |
99
+63
| +175% | +$1.91K | ﹤0.01% | 1864 |
|
2022
Q2 | $1K | Sell |
36
-18
| -33% | -$500 | ﹤0.01% | 2221 |
|
2022
Q1 | $4K | Sell |
54
-1
| -2% | -$74 | ﹤0.01% | 1689 |
|
2021
Q4 | $4K | Sell |
55
-5
| -8% | -$364 | ﹤0.01% | 1571 |
|
2021
Q3 | $6K | Buy |
60
+4
| +7% | +$400 | ﹤0.01% | 1182 |
|
2021
Q2 | $7K | Buy |
56
+12
| +27% | +$1.5K | ﹤0.01% | 1184 |
|
2021
Q1 | $6K | Buy |
44
+10
| +29% | +$1.36K | ﹤0.01% | 1200 |
|
2020
Q4 | $5K | Buy |
34
+4
| +13% | +$588 | ﹤0.01% | 1177 |
|
2020
Q3 | $3K | Sell |
30
-15
| -33% | -$1.5K | ﹤0.01% | 1257 |
|
2020
Q2 | $4K | Hold |
45
| – | – | ﹤0.01% | 1151 |
|
2020
Q1 | $3K | Buy |
45
+11
| +32% | +$733 | ﹤0.01% | 1182 |
|
2019
Q4 | $3K | Hold |
34
| – | – | ﹤0.01% | 1199 |
|
2019
Q3 | $3K | Sell |
34
-6
| -15% | -$529 | ﹤0.01% | 1168 |
|
2019
Q2 | $4K | Hold |
40
| – | – | ﹤0.01% | 1094 |
|
2019
Q1 | $3K | Hold |
40
| – | – | ﹤0.01% | 1156 |
|
2018
Q4 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 1163 |
|